Atlas Trials

Caveolin-1 and Vascular Dysfunction

Clinical trial NCT01426529 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01426529
Sponsor
Brigham and Women's Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
HypertensionInsulin Resistance
Start date
2010-10-01
Primary completion
2026-10-15
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.